HEADER TRANSFERASE 25-MAY-22 7ZZG TITLE CRYSTAL STRUCTURE OF NAD KINASE 1 FROM LISTERIA MONOCYTOGENES IN TITLE 2 COMPLEX WITH A LINEAR DI-ADENOSINE DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NAD KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ATP-DEPENDENT NAD KINASE; COMPND 5 EC: 2.7.1.23; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LISTERIA MONOCYTOGENES EGD-E; SOURCE 3 ORGANISM_TAXID: 169963; SOURCE 4 GENE: NADK1, LMO0968; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS TETRAMERIC NAD-KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.GELIN,G.LABESSE REVDAT 2 31-JAN-24 7ZZG 1 REMARK REVDAT 1 11-JAN-23 7ZZG 0 JRNL AUTH D.A.CLEMENT,M.GELIN,C.LESEIGNEUR,V.HUTEAU,L.MONDANGE, JRNL AUTH 2 J.L.PONS,O.DUSSURGET,C.LIONNE,G.LABESSE,S.POCHET JRNL TITL SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF JRNL TITL 2 ORIGINAL CYCLIC DIADENOSINE DERIVATIVES AS NANOMOLAR JRNL TITL 3 INHIBITORS OF NAD KINASE FROM PATHOGENIC BACTERIA. JRNL REF EUR.J.MED.CHEM. V. 246 14941 2023 JRNL REFN ISSN 0223-5234 JRNL PMID 36455355 JRNL DOI 10.1016/J.EJMECH.2022.114941 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 63.66 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 3 NUMBER OF REFLECTIONS : 22446 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1119 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 63.6600 - 4.6000 0.84 2472 102 0.1712 0.2102 REMARK 3 2 4.6000 - 3.6500 0.88 2570 124 0.1528 0.1970 REMARK 3 3 3.6500 - 3.1900 0.92 2681 137 0.1831 0.1885 REMARK 3 4 3.1900 - 2.9000 0.93 2689 144 0.1979 0.2513 REMARK 3 5 2.9000 - 2.6900 0.93 2716 141 0.2137 0.2474 REMARK 3 6 2.6900 - 2.5300 0.94 2722 153 0.2159 0.3191 REMARK 3 7 2.5300 - 2.4100 0.94 2700 163 0.2391 0.2756 REMARK 3 8 2.4100 - 2.3000 0.95 2777 155 0.2553 0.2859 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.900 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 1 THROUGH 120 ) REMARK 3 ORIGIN FOR THE GROUP (A): 13.0297 23.8370 19.2326 REMARK 3 T TENSOR REMARK 3 T11: 0.3457 T22: 0.3031 REMARK 3 T33: 0.3703 T12: 0.0454 REMARK 3 T13: 0.0038 T23: -0.0550 REMARK 3 L TENSOR REMARK 3 L11: 2.1510 L22: 1.4640 REMARK 3 L33: 7.9272 L12: -0.5516 REMARK 3 L13: -2.0208 L23: 1.1731 REMARK 3 S TENSOR REMARK 3 S11: 0.0333 S12: -0.3767 S13: 0.1934 REMARK 3 S21: 0.0886 S22: 0.0530 S23: 0.0527 REMARK 3 S31: -0.3627 S32: 0.1958 S33: -0.0826 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 121 THROUGH 264 ) REMARK 3 ORIGIN FOR THE GROUP (A): 20.3295 13.0307 -1.4244 REMARK 3 T TENSOR REMARK 3 T11: 0.1725 T22: 0.2183 REMARK 3 T33: 0.2731 T12: 0.0331 REMARK 3 T13: 0.0169 T23: 0.0085 REMARK 3 L TENSOR REMARK 3 L11: 2.1087 L22: 1.8023 REMARK 3 L33: 3.8197 L12: 0.1381 REMARK 3 L13: 0.2463 L23: 0.3908 REMARK 3 S TENSOR REMARK 3 S11: 0.0099 S12: 0.0583 S13: 0.0657 REMARK 3 S21: 0.0015 S22: -0.0205 S23: 0.1404 REMARK 3 S31: -0.0080 S32: -0.2446 S33: 0.0248 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZZG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1292123309. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.8-5.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.873128 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 128030 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.683 REMARK 200 RESOLUTION RANGE LOW (A) : 63.660 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.1 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.68 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.84500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.19.1_4122 REMARK 200 STARTING MODEL: 6RG9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30 MM NABR, 220 MM KCITRATE, GLYCEROL REMARK 280 6%, 15-16% W/V PEG400, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 31.69150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 37.67050 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 59.50400 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 31.69150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 37.67050 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 59.50400 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 31.69150 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 37.67050 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 59.50400 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 31.69150 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 37.67050 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 59.50400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 63.38300 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 63.38300 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 111 REMARK 465 GLY A 112 REMARK 465 LYS A 113 REMARK 465 LEU A 265 REMARK 465 GLU A 266 REMARK 465 HIS A 267 REMARK 465 HIS A 268 REMARK 465 HIS A 269 REMARK 465 HIS A 270 REMARK 465 HIS A 271 REMARK 465 HIS A 272 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 1 CG SD CE REMARK 470 LYS A 85 CG CD CE NZ REMARK 470 GLU A 94 CG CD OE1 OE2 REMARK 470 LYS A 108 CG CD CE NZ REMARK 470 GLN A 232 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 58 36.34 -141.55 REMARK 500 ASP A 77 54.99 -108.48 REMARK 500 TYR A 109 -142.09 -125.09 REMARK 500 ASN A 122 -74.71 -90.74 REMARK 500 SER A 129 25.19 -77.76 REMARK 500 ALA A 162 -122.31 -100.89 REMARK 500 ALA A 185 76.05 38.85 REMARK 500 ASN A 189 -157.76 -140.14 REMARK 500 HIS A 204 -3.24 71.31 REMARK 500 ASN A 213 -85.19 -132.33 REMARK 500 GLU A 263 144.89 -176.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7ZZ7 RELATED DB: PDB DBREF 7ZZG A 1 264 UNP Q8Y8D7 NADK1_LISMO 1 264 SEQADV 7ZZG LEU A 265 UNP Q8Y8D7 EXPRESSION TAG SEQADV 7ZZG GLU A 266 UNP Q8Y8D7 EXPRESSION TAG SEQADV 7ZZG HIS A 267 UNP Q8Y8D7 EXPRESSION TAG SEQADV 7ZZG HIS A 268 UNP Q8Y8D7 EXPRESSION TAG SEQADV 7ZZG HIS A 269 UNP Q8Y8D7 EXPRESSION TAG SEQADV 7ZZG HIS A 270 UNP Q8Y8D7 EXPRESSION TAG SEQADV 7ZZG HIS A 271 UNP Q8Y8D7 EXPRESSION TAG SEQADV 7ZZG HIS A 272 UNP Q8Y8D7 EXPRESSION TAG SEQRES 1 A 272 MET LYS TYR MET ILE THR SER LYS GLY ASP GLU LYS SER SEQRES 2 A 272 ASP LEU LEU ARG LEU ASN MET ILE ALA GLY PHE GLY GLU SEQRES 3 A 272 TYR ASP MET GLU TYR ASP ASP VAL GLU PRO GLU ILE VAL SEQRES 4 A 272 ILE SER ILE GLY GLY ASP GLY THR PHE LEU SER ALA PHE SEQRES 5 A 272 HIS GLN TYR GLU GLU ARG LEU ASP GLU ILE ALA PHE ILE SEQRES 6 A 272 GLY ILE HIS THR GLY HIS LEU GLY PHE TYR ALA ASP TRP SEQRES 7 A 272 ARG PRO ALA GLU ALA ASP LYS LEU VAL LYS LEU LEU ALA SEQRES 8 A 272 LYS GLY GLU TYR GLN LYS VAL SER TYR PRO LEU LEU LYS SEQRES 9 A 272 THR THR VAL LYS TYR GLY ILE GLY LYS LYS GLU ALA THR SEQRES 10 A 272 TYR LEU ALA LEU ASN GLU SER THR VAL LYS SER SER GLY SEQRES 11 A 272 GLY PRO PHE VAL VAL ASP VAL VAL ILE ASN ASP ILE HIS SEQRES 12 A 272 PHE GLU ARG PHE ARG GLY ASP GLY LEU CYS MET SER THR SEQRES 13 A 272 PRO SER GLY THR THR ALA TYR ASN LYS SER LEU GLY GLY SEQRES 14 A 272 ALA LEU MET HIS PRO SER ILE GLU ALA MET GLN LEU THR SEQRES 15 A 272 GLU MET ALA SER ILE ASN ASN ARG VAL TYR ARG THR ILE SEQRES 16 A 272 GLY SER PRO LEU VAL PHE PRO LYS HIS HIS VAL VAL SER SEQRES 17 A 272 LEU GLN PRO VAL ASN ASP LYS ASP PHE GLN ILE SER VAL SEQRES 18 A 272 ASP HIS LEU SER ILE LEU HIS ARG ASP VAL GLN GLU ILE SEQRES 19 A 272 ARG TYR GLU VAL SER ALA LYS LYS ILE HIS PHE ALA ARG SEQRES 20 A 272 PHE ARG SER PHE PRO PHE TRP ARG ARG VAL HIS ASP SER SEQRES 21 A 272 PHE ILE GLU ASP LEU GLU HIS HIS HIS HIS HIS HIS HET CIT A 301 13 HET KHL A 302 50 HETNAM CIT CITRIC ACID HETNAM KHL (1~{R},24~{R},25~{S},26~{R})-14-[[(2~{R},3~{S},4~{R}, HETNAM 2 KHL 5~{R})-5-(6-AMINOPURIN-9-YL)-3,4-BIS(OXIDANYL)OXOLAN- HETNAM 3 KHL 2-YL]METHYL]-7-AZANYL-25,26-BIS(OXIDANYL)-27-OXA-2,4, HETNAM 4 KHL 6,9,14,17,20,22-OCTAZATETRACYCLO[22.2.1.0^{2,10}.0^{3, HETNAM 5 KHL 8}]HEPTACOSA-3(8),4,6,9-TETRAEN-11-YNE-16,21-DIONE FORMUL 2 CIT C6 H8 O7 FORMUL 3 KHL C28 H34 N14 O8 FORMUL 4 HOH *53(H2 O) HELIX 1 AA1 ASP A 10 GLY A 25 1 16 HELIX 2 AA2 GLY A 44 TYR A 55 1 12 HELIX 3 AA3 GLU A 56 GLU A 61 5 6 HELIX 4 AA4 ARG A 79 ALA A 81 5 3 HELIX 5 AA5 GLU A 82 GLY A 93 1 12 HELIX 6 AA6 ALA A 162 LEU A 167 1 6 HELIX 7 AA7 PRO A 252 ILE A 262 1 11 SHEET 1 AA110 GLU A 30 TYR A 31 0 SHEET 2 AA110 LYS A 2 SER A 7 1 N TYR A 3 O GLU A 30 SHEET 3 AA110 ILE A 38 GLY A 43 1 O ILE A 40 N THR A 6 SHEET 4 AA110 ALA A 63 HIS A 68 1 O ILE A 67 N SER A 41 SHEET 5 AA110 GLU A 233 ARG A 247 1 O HIS A 244 N PHE A 64 SHEET 6 AA110 VAL A 207 PRO A 211 -1 N VAL A 207 O TYR A 236 SHEET 7 AA110 PHE A 133 ILE A 139 -1 N ASP A 136 O GLN A 210 SHEET 8 AA110 ILE A 142 SER A 155 -1 O GLU A 145 N VAL A 137 SHEET 9 AA110 ALA A 178 SER A 186 -1 O GLN A 180 N SER A 155 SHEET 10 AA110 LEU A 199 PRO A 202 -1 O PHE A 201 N MET A 179 SHEET 1 AA2 9 GLU A 115 ALA A 120 0 SHEET 2 AA2 9 GLN A 96 LYS A 108 -1 N VAL A 107 O ALA A 116 SHEET 3 AA2 9 GLU A 233 ARG A 247 -1 O PHE A 245 N VAL A 98 SHEET 4 AA2 9 VAL A 207 PRO A 211 -1 N VAL A 207 O TYR A 236 SHEET 5 AA2 9 PHE A 133 ILE A 139 -1 N ASP A 136 O GLN A 210 SHEET 6 AA2 9 ILE A 142 SER A 155 -1 O GLU A 145 N VAL A 137 SHEET 7 AA2 9 GLU A 123 SER A 128 -1 N SER A 124 O MET A 154 SHEET 8 AA2 9 PHE A 217 VAL A 221 -1 O SER A 220 N THR A 125 SHEET 9 AA2 9 LEU A 224 HIS A 228 -1 O ILE A 226 N ILE A 219 CRYST1 63.383 75.341 119.008 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015777 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013273 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008403 0.00000